- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03872089
Transient Thermal Behavior and Diabetic Foot (PICOTE)
December 9, 2021 updated by: University Hospital, Montpellier
In our study, the investigators propose to analyze the transient thermal responses taken at the level of the sole of the foot, following the application of a cold stimulus.
By combining a spatio-temporal analysis of these temperature fields and a thermal modeling of the heat transfer in the thickness of the foot, the investigators want to highlight differences between healthy feet vs. pathological feet.
Therefore, the investigators will determine the transient thermal responses at the level of the sole of the foot and correlate them with the podological grade.
Study Overview
Status
Terminated
Intervention / Treatment
Detailed Description
Both plants of the patient's feet will be observed by a thermal camera.
Static observations (taking a single image), or dynamic (taking a series of images) of the foot, will be made.
In the latter case, the observation will be done after a brisk walk of 6 min.
The instruction given to patients will be to go the furthest in 3 min and then come back in 3 min, all while walking.
The observation will be made by cameras without contact.
These thermal cameras are non-invasive and non-ionizing, there is no risk related to their use.
The camera will be placed on a tripod, a few tens of centimeters from the foot, and connected to a laptop (for the images acquisition).
A wooden box, painted black, will be placed around both feet to protect the scene from parasitic thermal radiation that can disturb temperature variations.
Foam will protect the skin / wood interface.
Electric resistances, fixed on the box, will be placed in the field of vision of the thermal camera to guarantee the good treatment of the images.
These resistors will never be in contact with the patient.
The area filmed by the camera will be limited to the sole arch and, sometimes, the hand of patients to see if a thermal anomaly is also present on this member.
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Montpellier, France, 34295
- CHU Montpellier - Lapeyronie hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diabetic subjects (type 1 and 2)
- age above 18 years old
- able to walk
- affiliate to insurance regimen
Exclusion Criteria:
- unable to stay motionless
- pregnancy
- subjects with feet wound
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study participants
Measurements of the temperature of the plantar arch by thermal imaging.
Result analysis regarding podologic grade ( 0-1-2-3)
|
Measurements of the temperature of the plantar arch by thermal imaging (Infrared Thermography)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thermal signals measured on plantar foot
Time Frame: At the inclusion
|
Determine the transient thermal responses at the plantar foot
|
At the inclusion
|
Correlation with podologic grade
Time Frame: At the inclusion
|
The classification of foot risk, mentioned in 2007 in the HAS report, is as follows ([HAS 2007]) Diabetic Foot Report http://www.has-sante.fr/portail/upload/docs/application/pdf/_foot_diabetic.pdf, 2007 :
|
At the inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ariane Sultan, MD-PhD, Equipe Nutrition Diabete- CHU Lapeyronie- Montpellier
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 8, 2019
Primary Completion (Actual)
October 8, 2019
Study Completion (Actual)
April 8, 2020
Study Registration Dates
First Submitted
February 22, 2019
First Submitted That Met QC Criteria
March 11, 2019
First Posted (Actual)
March 13, 2019
Study Record Updates
Last Update Posted (Actual)
December 30, 2021
Last Update Submitted That Met QC Criteria
December 9, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHMPL18_0371
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Patients Type 1 and 2
-
Hadassah Medical OrganizationUnknownUncontrolled Type 1 Diabetic Patients
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
Beni-Suef UniversityRecruitingType-2 Diabetic PatientsEgypt
-
GWT-TUD GmbHCompleted
-
Isfahan University of Medical SciencesShahid Motahari Hospital of Fooladshahr, Isfahan Steel Company, IsfahanCompletedType 2 Diabetic PatientsIran, Islamic Republic of
-
Hadassah Medical OrganizationCompletedObese Type 2 Diabetic Patients
-
Beijing HospitalUnknown
-
Tokyo Study GroupCompletedGAD Ab Positive Clinically Type 2 Diabetic PatientsJapan
-
Cairo UniversityNot yet recruitingDiabetic Pediatric Patients With Type 1 Diabetes
Clinical Trials on Infrared Thermography
-
University Hospital, Basel, SwitzerlandCompletedGlaucomaSwitzerland
-
Thermal Diagnostics LLCActive, not recruiting
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedFever, Sweats, and Hot FlashesUnited States
-
Zhejiang Chinese Medical UniversityRecruitingMajor Depressive Disorder | Infrared ThermographyChina
-
Zhejiang Chinese Medical UniversityThe Third Affiliated hospital of Zhejiang Chinese Medical University; The First...UnknownChronic Obstructive Pulmonary DiseaseChina
-
University Hospital of North NorwayCompleted
-
Shandong Cancer Hospital and InstituteUnknownBreast Neoplasm Female | Radiation Toxicity
-
RWTH Aachen UniversityCompleted
-
University Hospital of North NorwayUiT The Arctic University of NorwayUnknown